Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391794
Status:
COMPLETED
Last Update Posted:
2014-01-10
First Post:
2006-10-20
Brief Title:
Efficacy of Early Stage Alzheimers Support Groups
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Efficacy of Early Stage Alzheimers Support Groups
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the impact of an Early Stage Memory Loss Support Group ESSG and Education Seminar ES on quality of life mood social support distress about memory loss and interpersonal relationships of memory loss participants and their caregivers
Detailed Description:
With recent advances in diagnostic procedures and treatment options many individuals with AD are now diagnosed early in the disease Early diagnosis has many benefits treatment can be started sooner legal and financial planning can be addressed while the individual is able to participate in decision-making and support services can be mobilized earlier However early diagnosis may also have negative consequences for the diagnosed individuals quality of life Thus diagnosis creates an obligation to help individuals and their families learn more about AD and cope with the impact of the diagnosis Many Alzheimers Association chapters have begun providing early stage support groups that focus on enhancing quality of life for participants and their caregivers Anecdotal reports suggest that these groups improve quality of life of participants but some individuals may also experience decreases in quality of life associated with stress depression or family conflict as a result of discussing current and future losses in the group Thus there is a need to systematically evaluate the benefits of these groups
This study will evaluate and compare the efficacy of a structured 8-session Early Stage Support Group intervention ESSG and a half-day Education Seminar ES Participants with early stage memory loss and their caregivers will be randomly assigned to either ESSG or ES Both are presented by the Alzheimers Association Western Central Washington State Chapter
This study will evaluate and compare the efficacy of a structured 8-session Early Stage Support Group intervention ESSG and a half-day Education Seminar ES Participants with early stage memory loss and their caregivers will be randomly assigned to either ESSG or ES Both are presented by the Alzheimers Association Western Central Washington State Chapter
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5R01AG023091 | NIH | None | None |
| 06-1324-G01 | OTHER | None | None |
| 5R01AG023091-02 | NIH | None | None |
| 1A0131 | US NIH GrantContract | UW Human Subjects Division | httpsreporternihgovquickSearch5R01AG023091-02 |